5U01AG046161-05 |
2018 |
$1619042 |
Discovery of Novel Proteomic Targets for Treatment of Alzheimers Disease |
5U01AG046161-04 |
2017 |
$1631705 |
DISCOVERY OF NOVEL PROTEOMIC TARGETS FOR TREATMENT OF ALZHEIMER'S DISEASE |
3U01AG046161-04S1 |
2017 |
$156000 |
DISCOVERY OF NOVEL PROTEOMIC TARGETS FOR TREATMENT OF ALZHEIMER'S DISEASE |
5U01AG046161-03 |
2016 |
$1541709 |
DISCOVERY OF NOVEL PROTEOMIC TARGETS FOR TREATMENT OF ALZHEIMER'S DISEASE |
3U01AG046161-03S1 |
2016 |
$160872 |
DISCOVERY OF NOVEL PROTEOMIC TARGETS FOR TREATMENT OF ALZHEIMER'S DISEASE |
5U01AG046161-02 |
2015 |
$1516903 |
DISCOVERY OF NOVEL PROTEOMIC TARGETS FOR TREATMENT OF ALZHEIMER'S DISEASE |
3U01AG046161-02S1 |
2015 |
$132600 |
DISCOVERY OF NOVEL PROTEOMIC TARGETS FOR TREATMENT OF ALZHEIMER'S DISEASE |
1U01AG046161-01 |
2014 |
$1530583 |
DISCOVERY OF NOVEL PROTEOMIC TARGETS FOR TREATMENT OF ALZHEIMER'S DISEASE |